Treatment
-
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
Forward Look
Stem Cell Transplant Rates Decrease for LymphomaMore patients are receiving CAR T-cell therapy for large B-cell lymphoma.
by Leah Lawrence
-
Forward Look
Rethinking Cancer Drug DosesResearchers and patients push to move away from maximum tolerated dose in research.
by Natalie Slivinski
-
Reducing the Burden of RadiationShorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
by Stephen Ornes
-
Making Their MarkWith targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Cancer Care for Older AdultsGeriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.
by Eric Fitzsimmons
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
